Gastric bypass maintains weight loss and diabetes remission over 15 years, study shows

FHS
June 12, 2024
8:46 pm

Roux-en-Y gastric bypass, a type of weight-loss surgery, kept type 2 diabetes in remission for up to 15 years and most of the weight off for up to 20 years in one of the largest long-term studies of patients undergoing the procedure.

Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD | Psychedelic Invest

Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage pharmaceutical development company, is pleased to announce that

November 30, 2023

The future of Biogen: Pragmatism, ‘a few moonshots,’ and no Twinkies

Two years after a big scientific swing nearly pushed Biogen to the brink, CEO Christopher Viehbacher is embarking on a corporate rethink, one that balances

October 19, 2023

Tim Walz Beat COVID Skeptic Doc in 2022 Race for Governor

Minnesota Gov. Tim Walz (D) — who is now Kamala Harris’ pick for vice president — won reelection in 2022 after defeating Scott Jensen, MD,

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.